UnitedHealth Group Incorporated (UNH)
| Market Cap | 275.22B |
| Revenue (ttm) | 422.82B |
| Net Income (ttm) | 21.30B |
| Shares Out | 905.67M |
| EPS (ttm) | 23.12 |
| PE Ratio | 13.15 |
| Forward PE | 18.90 |
| Dividend | $8.84 (2.91%) |
| Ex-Dividend Date | Sep 15, 2025 |
| Volume | 9,982,781 |
| Open | 300.54 |
| Previous Close | 300.43 |
| Day's Range | 300.50 - 305.97 |
| 52-Week Range | 234.60 - 630.73 |
| Beta | 0.44 |
| Analysts | Buy |
| Price Target | 386.48 (+27.18%) |
| Earnings Date | Oct 14, 2025 |
About UNH
UnitedHealth Group Incorporated operates as a health care company in the United States and internationally. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older; Medicaid plans, children’s health insurance and health... [Read more]
Financial Performance
In 2024, UnitedHealth Group's revenue was $400.28 billion, an increase of 7.71% compared to the previous year's $371.62 billion. Earnings were $14.41 billion, a decrease of -35.64%.
Financial StatementsAnalyst Summary
According to 24 analysts, the average rating for UNH stock is "Buy." The 12-month stock price target is $386.48, which is an increase of 27.18% from the latest price.
News
Could Trump Target A Stake In UnitedHealth Next? Maybe
The Trump administration's unique investment in Intel Corp. INTC could be viewed as a template for how Washington may secure strategically vital industries by buying large stakes in publicly traded co...
UNH stock analysis: buy or sell UnitedHealth after the DoJ investigation news
UnitedHealth stock price has been on a roller-coaster in the past few months. It initially peaked at $620 in December last year and then plunged to a low of $235 this year, erasing billions of dollars...
UnitedHealth: A Generational Buying Opportunity
UnitedHealth's stock sell-off is overdone; the current valuation reflects temporary setbacks, not a structural decline, creating a generational buying opportunity. UNH's integrated insurance and healt...
Justice Department Investigates UnitedHealth Group Pharmacy Business and Doctor Reimbursements
A Justice Department criminal investigation of UnitedHealth Group is reportedly broader than initially thought. Bloomberg reported Tuesday (Aug.
UnitedHealth Stock Falls As Department Of Justice Criminal Probe Expands To Optum Rx: Report
UnitedHealth Group Inc UNH shares closed Tuesday's session lower following a Bloomberg report suggesting a U.S. Department of Justice criminal probe into the company is broader than previously known, ...
DoJ digging into UnitedHealth's prescription management services, Bloomberg News reports
The U.S. Justice Department's criminal division is digging into business practices at UnitedHealth Group's pharmacy benefit manager, Bloomberg News reported on Tuesday, citing people familiar with the...
UnitedHealth: 2026 Repricing Will Be A Game Changer
UNH's stock collapse is a rare blue-chip event, driven by temporary cost spikes and cyclical headwinds, not a broken business model. Insider and smart money buying—including Berskshire Hathaway's $1.6...
UnitedHealth: UNH Stock To $600?
With Warren Buffett's endorsement renewing investor confidence, the debate shifts from how low UnitedHealth stock could fall to how high it might rebound. At roughly 12 times trailing adjusted earning...
Buffett watchers cheer Berkshire's Apple and UnitedHealth bets — but wonder why he's sitting on so much cash
Warren Buffett's Berkshire Hathaway rejigged its portfolio and grew its cash pile last quarter. Close watchers of the company praised its UnitedHealth investment and sales of Apple stock.
UnitedHealth: Contrarians Should Have A Stomach For Volatility Until 2026
I initiate my coverage on UNH with a hold rating. Despite attractive valuation, with the P/E near 2014 levels and EV/EBITDA ~30% below sector median, I prefer to wait until the pessimism clears out. M...
UnitedHealth: One Of The Best Of Medical Services Industry
UNH stands out among peers for its strong dividend yield, consistent FCF generation, and expected double-digit dividend growth, making it my top healthcare pick. Despite recent setbacks—poor earnings,...
The Market Oversold UnitedHealth's Troubles
Berkshire Hathaway's $1.6B stake signals confidence in UnitedHealth, driving a sharp rally after a year of heavy declines and episodic setbacks. UNH's fundamentals remain robust: strong cash flow, sca...
Health care sector is resilient, 'won't stay down forever', says Evan May Wealth's Brooke Evans
Brooke May, Evans May Wealth managing partner, joins 'Closing Bell Overtime' to talk what sectors she is keeping an eye on in this market.
UnitedHealth's turnaround efforts underway
CNBC's Bertha Coombs joins 'Squawk on the Street' with the latest details on UnitedHealth Group's turnaround efforts after a tumultuous year for the company.
UnitedHealth: One Of The Best Risk-To-Reward Ratio On The Market
UnitedHealth: One Of The Best Risk-To-Reward Ratio On The Market
UnitedHealth: With Buffett Or Not, The Rally Is On
Warren Buffett's $1.57B position signals confidence, but UNH's rally stems from other factors beyond that. With Buffett or without him, I believe that UNH's rally should keep going. Management is aggr...
UNHG: Leveraging The UnitedHealth Rebound
The Leverage Shares 2X Long UNH Daily ETF offers leveraged exposure to UnitedHealth's stock via derivative positions with mild basis risk. Despite its recent recovery, we still see UnitedHealth as bei...
Healthcare Stocks Are Trading at Their Biggest Discount in 30 Years. Why a Turnaround May Have Already Started.
For investors worried about elevated market valuations, they may be just what the doctor ordered.
UnitedHealth Group: Buffett Leads A Contrarian Buying Spree
UnitedHealth Group has attracted major contrarian investors like Buffett, Burry, and Simons, signaling potential upside after heavy selling pressure. Despite recent turmoil, including leadership chang...
KKM's Jeff Kilburg gives 3 laggard names to buy right now
Jeff Kilburg, KKM Financial CEO, joins 'The Exchange' to discuss stock plays for 3 laggard names.
UnitedHealth Vs. Novo Nordisk: Which Healthcare Giant Fits Your Portfolio?
Two healthcare giants, UnitedHealth Group Inc UNH and Novo Nordisk A/S NVO, are duking it out in very different ways for investors' attention. Both stocks have faced heavy losses this year—UNH down 38...
Calls of the Day: UnitedHealth, Berkshire Hathaway and Cleveland-Cliffs
The Investment Committee discuss the latest Calls of the Day.
Berkshire's UnitedHealth Bet Highlights Long-Term Confidence Despite Depressed Earnings
On Friday, high-profile investors Michael Burry and Warren Buffett took positions in UnitedHealth Group Inc. UNH. Warren Buffett's fund bought little more than 5 million shares, and Burry disclosed in...
Stocks Muted Ahead Trump-Zelenskyy Meeting, First Solar Jumps: What's Moving Markets Monday?
Investor risk sentiment paused at the start of the week, as markets awaited details expected to emerge later when President Donald Trump meets with Ukrainian President Volodymyr Zelenskyy and European...